A connection between lung health and kidney function in adults with cystic fibrosis (CF), identifying early urinary markers ...

Research highlights gender-based disparities in lung transplantation, showing women face longer wait times yet achieve better ...

Analyst Joseph Schwartz of Leerink Partners reiterated a Buy rating on Insmed (INSM – Research Report), with a price target of $85.00.Stay ...

However, among those who received a lung transplant, fewer women died overall during follow-up (34.4% vs 42.7%, P <0.001), ...

the rate in pulmonary exacerbations through week 52, and the absolute change from baseline in the Cystic Fibrosis Questionnaire-Revised respiratory domain score through week 24 were also similar ...

Women are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to ...

Ensifentrine (Ohtuvayre) acts as bronchodilator and non-steroidal anti-inflammatory agent. It is formulated as suspension for inhalational route of administration. Ohtuvayre is indicated for the ...

Women who receive a lung transplant are more likely than men to live for five years post-transplant, according to new ...

Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant ...

ALX-1 is under clinical development by Vast Therapeutics and currently in Phase I for Bronchiectasis. According to GlobalData, Phase I drugs for Bronchiectasis have a 64% phase transition success rate ...

Data has revealed the most common reasons why people lodge claims for PIP. The number one reason is psychiatric disorders.